Atorvastatin improves inflammatory response in atherosclerosis by upregulating the expression of GARP

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Zhao, Xiaoqi ^a   Liu, Yuzhou ^a   Zhong, Yucheng ^a   Liu, Bo ^a   Yu, Kunwu ^a   Shi, Huairui ^a   Zhu, Ruirui ^a   Meng, Kai ^a   Zhang, Wei ^a   Wu, Bangwei ^a   Zeng, Qiutang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GLYCOPROTEIN; GLYCOPROTEIN A REPETITIONS PREDOMINANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; APOLIPOPROTEIN E; LRRC32 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE CULTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ATHEROSCLEROSIS; CELL CULTURE; DEFICIENCY; DRUG EFFECTS; GENETICS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM;

MUS;

ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; ATORVASTATIN CALCIUM; BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MICE; T-LYMPHOCYTES, REGULATORY;

EID: 84930666806     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/841472     Document Type: Article

References (32)

1. H. Ait-Oufella, B. L. Salomon, S. Potteaux et al., "Natural regulatory T cells control the development of atherosclerosis in mice", Nature Medicine, vol. 12, no. 2, pp. 178-180, 2006.
2. R. Klingenberg and G. K. Hansson, "Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies", European Heart Journal, vol. 30, no. 23, pp. 2838-2844, 2009.
3. P. Libby, P. M. Ridker, and G. K. Hansson, "Progress and challenges in translating the biology of atherosclerosis", Nature, vol. 473, no. 7347, pp. 317-325, 2011.
4. E. McNeill, K. M. Channon, and D. R. Greaves, "Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications", Clinical Science (Lond), vol. 118, no. 11, pp. 641-655, 2010.
5. N. C. Olson, R. Sallam, M. F. Doyle, R. P. Tracy, and S. A. Huber, "T helper cell polarization in healthy people: implications for cardiovascular disease", Journal of Cardiovascular Translational Research, vol. 6, no. 5, pp. 772-786, 2013.
6. D. A. Chistiakov, I. A. Sobenin, and A. N. Orekhov, "Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response", Immunology Letters, vol. 151, no. 1-2, pp. 10-22, 2013.
7. X. Meng, W. Li, J. Yang et al., "Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice", International Journal of Cardiology, vol. 168, no. 3, pp. 2684-2692, 2013.
8. L. L. Lintermans, C. A. Stegeman, P. Heeringa, and W. H. Abdulahad, "T cells in vascular inflammatory diseases", Frontiers in Immunology, vol. 5, article 504, 2014.
9. D.-X. Bu, G. Griffin, and A. H. Lichtman, "Mechanisms for the anti-inflammatory effects of statins", Current Opinion in Lipidology, vol. 22, no. 3, pp. 165-170, 2011.
10. M. K. Jain and P. M. Ridker, "Anti-inflammatory effects of statins: clinical evidence and basic mechanisms", Nature Reviews Drug Discovery, vol. 4, no. 12, pp. 977-987, 2005.
11. + T cells", Atherosclerosis, vol. 197, no. 2, pp. 829-839, 2008.
12. + T regulatory cells by modulation of transforming growth factor-β signal transduction", Immunology, vol. 130, no. 4, pp. 484-493, 2010.
13. + regulatory T cells in patients with acute coronary syndrome and the effects of atorvastatin", Journal of Huazhong University of Science and Technology, vol. 27, no. 5, pp. 524-527, 2007.
14. M. Battaglia and M. G. Roncarolo, "The Tregs' world according to GARP", European Journal of Immunology, vol. 39, no. 12, pp. 3296-3300, 2009.
15. H. Liewen, I. Meinhold-Heerlein, V. Oliveira et al., "Characterization of the human GARP (Golgi associated retrograde protein) complex", Experimental Cell Research, vol. 306, no. 1, pp. 24-34, 2005.
16. M. Probst-Kepper, R. Geffers, A. Kröger et al., "GARP: a key receptor controlling FOXP3 in human regulatory T cells", Journal of Cellular and Molecular Medicine, vol. 13, no. 9B, pp. 3343-3357, 2009.
17. + regulatory T cells", Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 32, pp. 13445-13450, 2009.
18. M. Probst-Kepper and J. Buer, "FOXP3 and GARP (LRRC32): the master and its minion", Biology Direct, vol. 5, article 8, 2010.
19. + T cells: a novel regulatory T cell subset", Journal of Immunology, vol. 184, no. 9, pp. 4620-4624, 2010.
20. T. Oida and H. L. Weiner, "TGF-β induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction", PLoS ONE, vol. 5, no. 11, Article ID e15523, 2010.
21. R. Wang, J. Zhu, X. Dong, M. Shi, C. Lu, and T. A. Springer, "GARP regulates the bioavailability and activation of TGFβ", Molecular Biology of the Cell, vol. 23, no. 6, pp. 1129-1139, 2012.
22. J. Stockis, D. Colau, P. G. Coulie, and S. Lucas, "Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg", European Journal of Immunology, vol. 39, no. 12, pp. 3315-3322, 2009.
23. J. P. Edwards, H. Fujii, A. X. Zhou, J. Creemers, D. Unutmaz, and E. M. Shevach, "Regulation of the expression of GARP/latent TGF-β1 complexes on mouse T cells and their role in regulatory T cell and Th17 differentiation", Journal of Immunology, vol. 190, no. 11, pp. 5506-5515, 2013.
24. + T cells", Nature Medicine, vol. 12, no. 6, pp. 627-635, 2006.
25. A. X. Zhou, L. Kozhaya, H. Fujii, and D. Unutmaz, "GARP-TGF-beta complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo", The Journal of Immunology, vol. 190, no. 10, pp. 5057-5064, 2013.
26. X. Meng, K. Zhang, J. Li et al., "Statins induce the accumulation of regulatory T cells in atherosclerotic plaque", Molecular Medicine, vol. 18, no. 4, pp. 598-605, 2012.
27. + regulatory T cells in experimental atherosclerosis", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 893-900, 2007.
28. A. P. da Cunha, H. Y. Wu, R. M. Rezende, T. Vandeventer, and H. L. Weiner, "In vivo anti-LAP mAb enhances IL-17/IFN-responses and abrogates anti-CD3-induced oral tolerance", International Immunology, vol. 27, no. 2, pp. 73-82, 2015.
29. C. Herder, W. Peeters, A. Zierer et al., "TGF-β1 content in atherosclerotic plaques, TGF-β1 serum concentrations and incident coronary events", European Journal of Clinical Investigation, vol. 42, no. 3, pp. 329-337, 2012.
30. N. Zhang, B. Schröppel, G. Lal et al., "Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response", Immunity, vol. 30, no. 3, pp. 458-469, 2009.
31. R. Zeiser, S. Youssef, J. Baker, N. Kambham, L. Steinman, and R. S. Negrin, "Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity", Blood, vol. 110, no. 13, pp. 4588-4598, 2007.
32. + lymphocytes", The Journal of Immunology, vol. 180, no. 10, pp. 6988-6996, 2008.